AUTHOR=Butt Michelle , Elliott LouAnn , Guy Fiona , Symington Amanda , Paes Bosco 

TITLE=Comparison of the Canadian vs. the international risk scoring tool for respiratory syncytial virus prophylaxis in moderate-to-late preterm infants

JOURNAL=Frontiers in Pediatrics

VOLUME=10

YEAR=2023

URL=https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2022.997349

DOI=10.3389/fped.2022.997349

ISSN=2296-2360

ABSTRACT=<sec><title>Aim</title><p>The study objective was to compare the Pediatric Investigators Collaborative Network on Infections in Canada risk scoring tool (CRST) that determines need for respiratory syncytial virus (RSV) prophylaxis in infants 33–35 weeks gestational age during the RSV season, with the newly developed international risk scoring tool (IRST).</p></sec><sec><title>Methods</title><p>Children 33–35 weeks gestational age born during the 2018–2021 RSV seasons were prospectively identified following birth and scored with the validated CRST and IRST, that comprises seven and three variables respectively, into low- moderate- and high-risk groups that predict RSV-related hospitalization. Correlations between total scores on the two tools, and cut-off scores for the low-, moderate- and high-risk categories were conducted using the Spearman rank correlation.</p></sec><sec><title>Results</title><p>Over a period of 3 RSV seasons, 556 infants were scored. Total risk scores on the CRST and the IRST were moderately correlated (<italic>r<sub>s</sub></italic> = 0.64, <italic>p</italic> &lt; 0.001). A significant relationship between the risk category rank on the CRST and the risk category rank on the IRST (<italic>r<sub>s</sub></italic><sub> </sub>= 0.53; <italic>p</italic> &lt; 0.001) was found. The proportion of infants categorized as moderate risk for RSV hospitalization by the CRST and IRST were 19.6% (<italic>n</italic> = 109) and 28.1% (<italic>n</italic> = 156), respectively.</p></sec><sec><title>Conclusion</title><p>The IRST may provide a time-efficient scoring alternative to the CRST with three vs. seven variables, and it selects a larger number of infants who are at moderate risk for RSV hospitalization for prophylaxis. A cost-utility analysis is necessary to justify country-specific use of the IRST, while in Canada a cost comparison is necessary between the IRST vs. the currently approved CRST prior to adoption.</p></sec>